These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 15703421)

  • 1. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
    Dragun D; Müller DN; Bräsen JH; Fritsche L; Nieminen-Kelhä M; Dechend R; Kintscher U; Rudolph B; Hoebeke J; Eckert D; Mazak I; Plehm R; Schönemann C; Unger T; Budde K; Neumayer HH; Luft FC; Wallukat G
    N Engl J Med; 2005 Feb; 352(6):558-69. PubMed ID: 15703421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
    Ansari MJ; Tinckam K; Chandraker A
    N Engl J Med; 2005 May; 352(19):2027-8; author reply 2027-8. PubMed ID: 15892197
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation.
    Thway TM; Shlykov SG; Day MC; Sanborn BM; Gilstrap LC; Xia Y; Kellems RE
    Circulation; 2004 Sep; 110(12):1612-9. PubMed ID: 15381659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.
    Yang X; Wang F; Chang H; Zhang S; Yang L; Wang X; Cheng X; Zhang M; Ma XL; Liu H
    J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against mesangial cells in a rat model of chronic renal allograft rejection.
    Joosten SA; van Ham V; Borrias MC; van Kooten C; Paul LC
    Nephrol Dial Transplant; 2005 Apr; 20(4):692-8. PubMed ID: 15701669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of signal transduction during vascular smooth muscle cell proliferation induced by autoantibodies against angiotensin AT1 receptor from hypertension.
    Sun YX; Zhang HY; Wei YM; Zhu F; Wang M; Liao YH
    Chin Med J (Engl); 2008 Jan; 121(1):43-8. PubMed ID: 18208665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.
    Reinsmoen NL; Lai CH; Heidecke H; Haas M; Cao K; Ong G; Naim M; Wang Q; Mirocha J; Kahwaji J; Vo AA; Jordan SC; Dragun D
    Transplantation; 2010 Dec; 90(12):1473-7. PubMed ID: 21030904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
    Hilbrands L; Hoitsma A; Wetzels J
    N Engl J Med; 2005 May; 352(19):2027-8; author reply 2027-8. PubMed ID: 15888709
    [No Abstract]   [Full Text] [Related]  

  • 10. Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia.
    Wallukat G; Neichel D; Nissen E; Homuth V; Luft FC
    Can J Physiol Pharmacol; 2003 Feb; 81(2):79-83. PubMed ID: 12710518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection.
    Dragun D
    Pediatr Nephrol; 2007 Jul; 22(7):911-4. PubMed ID: 17340146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies.
    Lukitsch I; Kehr J; Chaykovska L; Wallukat G; Nieminen-Kelhä M; Batuman V; Dragun D; Gollasch M
    Transplantation; 2012 Jul; 94(1):8-13. PubMed ID: 22691955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies.
    Fuss A; Hope CM; Deayton S; Bennett GD; Holdsworth R; Carroll RP; Coates PT
    Nephrology (Carlton); 2015 Jul; 20(7):467-73. PubMed ID: 25726938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonistic antibody-triggered stimulation of Angiotensin II type 1 receptor and renal allograft vascular pathology.
    Dragun D
    Nephrol Dial Transplant; 2007 Jul; 22(7):1819-22. PubMed ID: 17517802
    [No Abstract]   [Full Text] [Related]  

  • 16. Agonistic autoantibodies and rejection of renal allografts.
    Ingelfinger JR
    N Engl J Med; 2005 Feb; 352(6):617-9. PubMed ID: 15703427
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis.
    Chan YC; Leung PS
    J Pharmacol Exp Ther; 2007 Oct; 323(1):10-8. PubMed ID: 17616560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
    Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.